Launch of Website; Corporate Update

AI SummaryClose X

ImmuPharma PLC has launched its new corporate website and provided a corporate update. A new P140 patent has been filed, potentially extending patent protection until 2045, and the company is engaging with potential partners, offering access to a comprehensive data room upon signing a Confidential Disclosure Agreement, with the objective of completing a deal by the end of 2025. ImmuPharma's cash runway has been extended into H2 2026 through warrant exercises and enhanced monthly cash receipts under the Lanstead Capital sharing agreement. The final settlement for the Lanstead Capital sharing agreement is expected in November. The company has stated it has no intention to raise further funds.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings